Compelling evidence also showed that YAP1 can alter the TME by recruiting immunosuppressive cell types, suppressing cytotoxic T-cell function or promoting the polarization of tumor-associated macrophages towards the pro-tumor M2 phenotype (72–74). The gene discussed is YAP1; the disease is neoplasm.